Can the longs shed light on the deception and distortion of shorts
under the post of Salseroomega Latest Presentation
some shorts are claiming SNTS won't be able to beat and mostly likely they will miss because UCERIS sales have stagnated and SNTS will have to make it 15000 prescriptions to meet the revenue estimates.
SNTS needs only 15% to make new 52 week highs which is not a big deal, I personally believe that it will cross above $30 in the comings month. Which is 20% from $25
They only need to increase TOTAL revs $4.24 to meet the estimate. Uceris will add most of this, but the other products can add more than that. The company gave guidance last earnings CC that they plan to make easily IMO. Also, look at earnings projections $1.62 in 2014 and $2.12 in 2015. That is growth for you. Shortie is being swept under a losing short position.